Browsing by Author Roux, C

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 3 to 6 of 6 < previous 
TitleAuthor(s)Issue DateViews
 
IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functions
Journal:Proceedings of the National Academy of Sciences
Mucciolo, GCurcio, CRoux, CLi, WYCapello, MCurto, RChiarle, RGiordano, DSatolli, MALawlor, RScarpa, ALukac, PStakheev, DProvero, PVannucci, LMak, TWNovelli, FCappello, P
2021
2
 
Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis
Journal:Osteoporosis International
Roux, CReid, DMDevogelaer, JPSaag, KLau, CSReginster, JYPapanastasiou, PBucciRechtweg, CSu, GSambrook, PN
2012
176
 
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (health outcomes and reduced incidence with zoledronic acid once yearly trial): A multicentre, double-blind, double-dummy, randomized controlled trial
Journal:Obstetrical and Gynecological Survey
Reid, DMDevogelaer, JPSaag, KRoux, CLau, CSReginster, JYPapanastasiou, PFerreira, AHartl, FFashola, TMesenbrink, PSambrook, PN
2009
154
 
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
Journal:The Lancet
Reid, DMDevogelaer, JPSaag, KRoux, CLau, CSReginster, JYPapanastasiou, PFerreira, AHartl, FFashola, TMesenbrink, PSambrook, PN
2009
166
Showing results 3 to 6 of 6 < previous